Drugs / Hematopoietic Stem Cells from HLA Unrelated
Hematopoietic Stem Cells from HLA Unrelated
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04684979 | Mar 2022 → Mar 2026 | B-cell neoplasm, non-Hodgkin lymphoma | Baptist Health South Florida | Withdrawn | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Hematopoietic Stem Cells from HLA Unrelated | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04684979 ↗ |
| Modality | Cell therapy | “Hematopoietic Stem Cells from HLA Unrelated” NCT04684979 ↗ |